Insights into peptide and protein function: A convergent approach

Journal of Peptide Science

Volumn 7, Issue 2, 2001, Pages 63-73

  Alexopoulos, Charalampos ^a   Tsikaris, Vassilios ^a   Rizou, Catherina ^a   Panou Pomonis, Eugenia ^a   Sakarellos Daitsiotis, Maria ^a   Sakarellos, Constantinos ^a   Vlachoyiannopoulos, Panayiotis G ^b   Moutsopoulos, Haralampos M ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Analgesia; Apoptosis; CCK8; HIV 1 proteins; Metallopeptidase inhibitors; Peptidomimetics; Rational drug design

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR; DRUG METABOLIZING ENZYME; ENDORPHIN DERIVATIVE; ENKEPHALIN; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR; GAMMA ENDORPHIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUCINE ENKEPHALIN; LIGAND; METENKEPHALIN; MORPHINE DERIVATIVE; NEUROPEPTIDE; NEUROTRANSMITTER; PEPTIDASE; PEPTIDE; PEPTIDE DERIVATIVE; PROTEIN; PROTEIN DERIVATIVE; REGULATOR PROTEIN; SUBSTANCE P; SUBSTANCE P ANTAGONIST; TETRAGASTRIN; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BIOCHEMISTRY; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOLOGY; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; GENE CONTROL; GENETIC ANALYSIS; GUINEA PIG; MOLECULAR BIOLOGY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RAT; REGULATORY MECHANISM; REVIEW; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; VIRUS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; ENDOPEPTIDASES; GUINEA PIGS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; PAIN; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEINS; RATS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035098771     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.315     Document Type: Review

References (57)

1. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology
2. Recent advances in the design and development of vasopeptidase inhibitors
3. Novel approaches to targeting neuropeptide systems
4. Identification of two related pentapeptides from the brain with potent opiate agonist activity
5. New peptide in vertebrate CNS reacting with antigastrin antibodies
6. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides
7. Efficacy in drug receptor theory out dated concept or under-valued tool?
8. Allosteric receptor after 30 years
9. Conformation of the endogenous opiate-like pentapeptide Met-enkephalin determined by high field NMR spectroscopy
10. A crystal molecular conformation of leucine-enkephalin related to the morphine molecule
11. 1H NMR spectroscopy, fluorescence transfer measurements and calculations
12. Structural requirements for specific recognition of mu or delta opiate receptors
13. 3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma-glioma hybrid cell line (NG 108-15)
14. Cyclic cholecystokinin analogues highly selective towards central receptors
15. Crystal structure of Rhodopsin: G protein-coupled receptor
16. Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis
17. Molecular mechanism of opioid receptor selection
18. Evidence of the preferential involvement of mu-receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptors
19. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
20. 1 receptor stimulation
21. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses
22. Heterogeneity of CCK-B receptors involved in animal models of anxiety
23. The CCK-B agonist, BC 264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats
24. Structure, distribution and functions of CCK receptors using the rational nomenclature defined by the International Union of Pharmacology
25. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
26. Rewards versus anxiety: The opposite pharmacology of opioids and CCK
27. Cholecystokinin and panic disorder
28. Development of new potent agonists able to interact with two postulated subsites of the cholecystokinin CCK-B receptor
29. Synthesis of new amino acids mimicking sulfated and phosphorylated tyrosine residues
30. Enkephalin degrading enzyme inhibitors: A physiological way to new analgesics and psychoactive agents
31. Structural basis of the action of thermolysin and related zinc peptidases
32. Evidence by site directed mutagenesis that arginine 203 of thermolysin and arginine 717 of neutral endopeptidase play equivalent critical roles in substrate hydrolysis and inhibitor binding
33. Zinc metallopeptidases: Active site structure and design of selective and mixed inhibitors - New approaches in the search for analgesics and antihypertensives
34. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice
35. Design of specific inhibitors of engiotensin-converting enzyme: New class of orally active antihypertensive agents
36. Complete differentiation between 'enkephalinase' and angiotensin converting enzymes inhibition by retro-thiorphan
37. Neutral endopeptidase-24, 11 inhibitors: From analgesics to antihypertensives?
38. A three-dimensional construction of the active site (region 507-749) of human neutral endopeptidase (EC 3.4.24.11)
39. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon
40. Peptide hydroxamic acids as inhibitors of thermolysin
41. Comparative distribution of the neutral endopeptidase 'enkephalinase' and mu and delta opioid receptors in rat brain by autoradiography
42. Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: A new class of central analgesics
43. Aminopeptidase A inhibitors as potential central antihypertensive agents
44. Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels
45. Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin L chain
46. Inhibitors of Ras signal transduction as antitumor agents
47. 1H NMR
48. The nucleocapsid protein NCp7 of HIV-1 as a potential target for the design of novel antiviral agents
49. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses
50. Direct in vitro interaction between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1
51. A mimic of HIV-1 NC protein impairs reverse transcription and display antiviral activity
52. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: Molecular insights into its biological functions
53. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
54. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes
55. DNA binding properties of a chemically synthesized DNA-binding domain of HRFX1
56. Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding